Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer

L Yu, J Wei, P Liu - Seminars in cancer biology, 2022 - Elsevier
Cancer is the second leading cause of human death globally. PI3K/Akt/mTOR signaling is
one of the most frequently dysregulated signaling pathways observed in cancer patients that …

Liver cancer cell of origin, molecular class, and effects on patient prognosis

D Sia, A Villanueva, SL Friedman, JM Llovet - Gastroenterology, 2017 - Elsevier
Primary liver cancer is the second leading cause of cancer-related death worldwide and
therefore a major public health challenge. We review hypotheses of the cell of origin of liver …

Prospective genotyping of hepatocellular carcinoma: clinical implications of next-generation sequencing for matching patients to targeted and immune therapies

JJ Harding, S Nandakumar, J Armenia, DN Khalil… - Clinical Cancer …, 2019 - AACR
Purpose: Prior molecular profiling of hepatocellular carcinoma (HCC) has identified
actionable findings that may have a role in guiding therapeutic decision-making and clinical …

Role of the mammalian target of rapamycin pathway in liver cancer: from molecular genetics to targeted therapies

X Lu, P Paliogiannis, DF Calvisi, X Chen - Hepatology, 2021 - Wiley Online Library
Primary liver cancers, including hepatocellular carcinoma (HCC) and intrahepatic
cholangiocarcinoma (iCCA), are highly lethal tumors, with high worldwide frequency and …

[HTML][HTML] Metabolic reprogramming in cancer cells: emerging molecular mechanisms and novel therapeutic approaches

C Navarro, Á Ortega, R Santeliz, B Garrido, M Chacín… - Pharmaceutics, 2022 - mdpi.com
The constant changes in cancer cell bioenergetics are widely known as metabolic
reprogramming. Reprogramming is a process mediated by multiple factors, including …

Infection and cancer: the case of hepatitis B

SL Chan, VWS Wong, S Qin, HLY Chan - Journal of Clinical Oncology, 2016 - ascopubs.org
Infection is a well-described cause of cancer in humans. Being one of the most common
infections worldwide, hepatitis B virus (HBV) is the leading cause of hepatocellular …

mTORC1/2 inhibition preserves ovarian function and fertility during genotoxic chemotherapy

KN Goldman, D Chenette, R Arju… - Proceedings of the …, 2017 - National Acad Sciences
The ovary contains oocytes within immature (primordial) follicles that are fixed in number at
birth. Activation of follicles within this fixed pool causes an irreversible decline in …

[HTML][HTML] Inhibiting glutamine-dependent mTORC1 activation ameliorates liver cancers driven by β-catenin mutations

AOA Michael, S Ko, J Tao, A Moghe, H Yang, M Xu… - Cell metabolism, 2019 - cell.com
Based on their lobule location, hepatocytes display differential gene expression, including
pericentral hepatocytes that surround the central vein, which are marked by Wnt-β-catenin …

[HTML][HTML] mTOR cross-talk in cancer and potential for combination therapy

F Conciatori, L Ciuffreda, C Bazzichetto, I Falcone… - Cancers, 2018 - mdpi.com
The mammalian Target of Rapamycin (mTOR) pathway plays an essential role in sensing
and integrating a variety of exogenous cues to regulate cellular growth and metabolism, in …

[HTML][HTML] Tuberous sclerosis complex

H Northrup, MK Koenig, DA Pearson, KS Au - 2021 - europepmc.org
Tuberous sclerosis complex (TSC) involves abnormalities of the skin (hypomelanotic
macules, confetti skin lesions, facial angiofibromas, shagreen patches, fibrous cephalic …